Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lebrec

Gut

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Gut|August 21, 2001
Drug therapy for portal hypertensionD Lebrec
Gut|October 16, 2001
Life, death, and varicesD Lebrec
Gut|November 1, 1980
Portal hypertension in fulminant viral hepatitisD Lebrec, O Nouel, J Bernuau, et al.
Gut|October 1, 1986
Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosisA Braillon, P Cales, D Valla, et al.
Gut|February 1, 1991
Sinusoidal portal hypertension in hepatic amyloidosisE Bion, R Brenard, E A Pariente, et al.
Gut|June 1, 1979
Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantationC Nataf, G Feldmann, D Lebrec, et al.
Gut|July 16, 2002
Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patientsS Hillaire, E Bonte, M-H Denninger, et al.
Gut|June 16, 1999
Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosisA Gadano, R Moreau, J Heller, et al.
Gut|November 16, 2004
Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic ratsW Urbanowicz, P Sogni, R Moreau, et al.
Gut|January 5, 2002
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot studyR Moreau, T Asselah, B Condat, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Gut|August 21, 2001
Drug therapy for portal hypertensionD Lebrec
Gut|October 16, 2001
Life, death, and varicesD Lebrec
Gut|November 1, 1980
Portal hypertension in fulminant viral hepatitisD Lebrec, O Nouel, J Bernuau, et al.
Gut|October 1, 1986
Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosisA Braillon, P Cales, D Valla, et al.
Gut|February 1, 1991
Sinusoidal portal hypertension in hepatic amyloidosisE Bion, R Brenard, E A Pariente, et al.
Gut|June 1, 1979
Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantationC Nataf, G Feldmann, D Lebrec, et al.
Gut|July 16, 2002
Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patientsS Hillaire, E Bonte, M-H Denninger, et al.
Gut|June 16, 1999
Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosisA Gadano, R Moreau, J Heller, et al.
Gut|November 16, 2004
Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic ratsW Urbanowicz, P Sogni, R Moreau, et al.
Gut|January 5, 2002
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot studyR Moreau, T Asselah, B Condat, et al.
Pageof 1